Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Nifty 50, Sensex fall for 4th day, shed 0.5% as bears continue to rule; auto, pharma stocks top drags
Stock Market Today: The Indian stock market faced renewed selling pressure on February 21, with heavy losses in auto and pharma stocks dragging the frontline
Divi’s Labs share price dips 4% as SBI Mutual Fund trims stake in pharma company
Stock market today: Shares of pharma major Divi’s Laboratories on Friday, February 21, witnessed a near 4% decline in intra-day trade after SBI Mutual Fund
Stock market today: Birlasoft to Natco Pharma— 155 BSE-listed shares hit 52-week low. Do you own any?
Stock market today: Advanced Enzyme Technologies, Birlasoft, Cera Sanitaryware, Go Colors India, Grindwell Norton, Jamna Auto Industries, Kajaria Ceramics, Kirloskar Oil Engines, Natco Pharma, and
Small-cap stock below ₹50: Pharma stock jumps 6% from today’s low on this acquisition buzz
Small-cap stock below ₹50: Pharma stock , Sudarshan Pharma lndustries jumps 6% from today’s low in the stock market today on this acquisition buzz Sudarshan
Macquarie initiates outperform rating on 4 Indian pharma stocks, sees 19-35% upside. Here’s why
Indian pharma stocks: Macquarie Equity Research has initiated outperform ratings for Divi’s Labs, Suven Pharma, Bluejet Healthcare, and Syngene. Among the 11 companies covered in
Trump tariffs on pharma: Natco Pharma is scouting for acquisitions in US, RoW markets
Natco Pharma is scouring for acquisitions in the US and Rest of the World (RoW) markets, according to its Vice-Chairman and Chief Executive Officer, Rajeev Nannapaneni.
52 Week Low Stocks Today on February 20, 2025: Natco Pharma, VIP Industries & others hit 52 week low today ;Check the full list here
52 Week Low Stocks Today on February 20, 2025: Shares of Natco Pharma, VIP Industries, Dollar Industries, Birlasoft, Grindwell Norton hit their fresh 52 wk
President Trump ups the ante on tariffs, Indian pharma underscores its role in affordable medicines
As US President Donald Trump reiterated his plans for tariffs on products including pharmaceuticals, Indian drugmakers underscored their role in keeping medicines affordable in the
President Trump ups the ante on tariffs, Indian pharma underscores its role in affordable medicines
As US President Donald Trump reiterated his plans for tariffs on products including pharmaceuticals, Indian drugmakers underscored their role in keeping medicines affordable in the
Top Gainers & Top Losers Today 19th Feb 2025: BEL, L&T, Axis Bank, Hindalco and NTPC lead gains, IT & pharma stocks face pressure
Shares of Bharat Electronics, Larsen & Turbo, Axis Bank, Hindalco, and NTPC emerged as top gainers among Nifty 50 constituents on Wednesday’s intraday trading session.